Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A07760 | 32362329 | Prog Med Chem | P2X7 receptor antagonists for the treatment of systemic inflammatory disorders. | 2020 | Details |
| A07761 | 32362324 | Immunity | Niche-Specific Reprogramming of Epigenetic Landscapes Drives Myeloid Cell Diversity in Nonalcoholic Steatohepatitis. | 2020 | Details |
| A07764 | 32360826 | Clin Gastroenterol Hepatol | Decreased Quality of Life Is Significantly Associated With Body Composition in Patients With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A07765 | 32360822 | Clin Gastroenterol Hepatol | PNPLA3 Gene Polymorphism and Liver- and Extrahepatic Cancer-Related Mortality in the United States. | 2020 | Details |
| A07766 | 32360810 | Clin Gastroenterol Hepatol | Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis. | 2020 | Details |
| A07767 | 32360804 | Clin Gastroenterol Hepatol | Intragastric Balloon Placement Induces Significant Metabolic and Histologic Improvement in Patients With Nonalcoholic Steatohepatitis. | 2020 | Details |
| A07768 | 32360637 | Cell Mol Gastroenterol Hepatol | Diet Reversal and Immune Modulation Show Key Role for Liver and Adipose Tissue T Cells in Murine Nonalcoholic Steatohepatitis. | 2020 | Details |
| A07769 | 32360434 | J Hepatol | Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages☆. | 2020 | Details |
| A07771 | 32360132 | Dig Liver Dis | Mitochondrial DNA from hepatocytes induces upregulation of interleukin-33 expression of macrophages in nonalcoholic steatohepatitis. | 2020 | Details |
| A07772 | 32359748 | Clin Nutr ESPEN | Diagnostic of hepatic fibrosis with the XL probe of the Fibroscan versus biopsies in patients candidates to bariatric surgery. | 2020 | Details |
| A07773 | 32359737 | Clin Nutr ESPEN | Effects of the Mediterranean diet on cardiovascular risk factors in non-alcoholic fatty liver disease patients: A systematic review and meta-analysis. | 2020 | Details |
| A07775 | 32359355 | Cardiovasc Diabetol | Fatty liver index and development of cardiovascular disease in Koreans without pre-existing myocardial infarction and ischemic stroke: a large population-based study. | 2020 | Details |
| A07776 | 32357561 | Int J Mol Sci | The Molecular and Mechanistic Insights Based on Gut-Liver Axis: Nutritional Target for Non-Alcoholic Fatty Liver Disease (NAFLD) Improvement. | 2020 | Details |
| A07777 | 32357501 | Nutrients | Assessing Non-Invasive Liver Function in Patients with Intestinal Failure Receiving Total Parenteral Nutrition-Results from the Prospective PNLiver Trial. | 2020 | Details |
| A07778 | 32357187 | PLoS One | Berberine inhibits free fatty acid and LPS-induced inflammation via modulating ER stress response in macrophages and hepatocytes. | 2020 | Details |
| A07779 | 32356922 | Diabetes Metab Res Rev | Non-alcoholic fatty liver disease is associated with cardiovascular disease in subjects with different glucose tolerance. | 2020 | Details |
| A07781 | 32355844 | Ann Transl Med | The cellular pathways of liver fibrosis in non-alcoholic steatohepatitis. | 2020 | Details |
| A07782 | 32355752 | Ann Transl Med | Shorter leucocyte telomere length as a potential biomarker for nonalcoholic fatty liver disease-related advanced fibrosis in T2DM patients. | 2020 | Details |
| A07785 | 32355283 | Nat Commun | Dysregulation of bile acids increases the risk for preterm birth in pregnant women. | 2020 | Details |
| A07786 | 32354883 | In Vivo | Oral Recombinant Methioninase Prevents Nonalcoholic Fatty Liver Disease in Mice on a High Fat Diet. | 2021 | Details |
| A07787 | 32354880 | In Vivo | Pathophysiological Changes During Ischemia-reperfusion Injury in Rodent Hepatic Steatosis. | 2021 | Details |
| A07788 | 32354858 | Diabetes | The Effects of B1344, a Novel Fibroblast Growth Factor 21 Analog, on Nonalcoholic Steatohepatitis in Nonhuman Primates. | 2020 | Details |
| A07789 | 32354182 | J Clin Med | Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational Research. | 2020 | Details |
| A07790 | 32354071 | Pharmaceutics | NAFLD Aggravates Septic Shock Due to Inadequate Adrenal Response and 11β-HSDs Dysregulation in Rats. | 2020 | Details |
| A07791 | 32353589 | Pharmacol Res | 18β-Glycyrrhetinic acid acts through hepatocyte nuclear factor 4 alpha to modulate lipid and carbohydrate metabolism. | 2020 | Details |
| A07792 | 32353483 | J Hepatol | Standardisation of diet and exercise in clinical trials of NAFLD-NASH: Recommendations from the Liver Forum. | 2020 | Details |
| A07793 | 32353385 | Toxicol Appl Pharmacol | Metabolomic-based assessment reveals dysregulation of lipid profiles in human liver cells exposed to environmental obesogens. | 2020 | Details |
| A07796 | 32353039 | PLoS Med | Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies. | 2020 | Details |
| A07797 | 32352707 | Clin Transl Gastroenterol | Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC. | 2020 | Details |
| A07798 | 32352687 | Clin Transl Gastroenterol | Accuracy of Noninvasive Fibrosis Scoring Systems in African American and White Patients With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A07799 | 32352682 | Clin Transl Gastroenterol | The Association Between Cholecystectomy, Metabolic Syndrome, and Nonalcoholic Fatty Liver Disease: A Population-Based Study. | 2020 | Details |
| A07801 | 32351917 | Front Pediatr | Nonalcoholic Fatty Liver Disease Is Associated With Low Skeletal Muscle Mass in Overweight/Obese Youths. | 2020 | Details |
| A07802 | 32351294 | World J Gastroenterol | Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease. | 2020 | Details |
| A07803 | 32351286 | World J Gastroenterol | Determining the role for uric acid in non-alcoholic steatohepatitis development and the utility of urate metabolites in diagnosis: An opinion review. | 2020 | Details |
| A07804 | 32351187 | Curr Diabetes Rev | Inter-Tissue and Intra-Tissue Co-Expression Networks in Human Metabolism: Morphological Evaluation of the Link Between Transcription Factors ERβ and NFAT in Morbid Obesity. | 2021 | Details |
| A07805 | 32351030 | Pediatr Obes | The relationship between pancreas steatosis and the risk of metabolic syndrome and insulin resistance in Chinese adolescents with concurrent obesity and non-alcoholic fatty liver disease. | 2020 | Details |
| A07806 | 32350824 | J Endocrinol Invest | Circulating levels of fetuin-A are associated with moderate-severe hepatic steatosis in young adults. | 2020 | Details |
| A07807 | 32350271 | Nat Commun | Partial impairment of insulin receptor expression mimics fasting to prevent diet-induced fatty liver disease. | 2020 | Details |
| A07808 | 32350181 | J Nutr Sci Vitaminol (Tokyo) | Coleus forskohlii Extract Attenuated the Beneficial Effect of Diet-Treatment on NASH in Mouse Model. | 2020 | Details |
| A07809 | 32349939 | Ann Hepatol | Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity. | 2020 | Details |
| A07810 | 32349708 | BMC Gastroenterol | High incidence of hepatocellular carcinoma and cirrhotic complications in patients with psychiatric illness: a territory-wide cohort study. | 2020 | Details |
| A07812 | 32349377 | Int J Mol Sci | Possible Relevance of PNPLA3 and TLL1 Gene Polymorphisms to the Efficacy of PEG-IFN Therapy for HBV-Infected Patients. | 2020 | Details |
| A07813 | 32349225 | Molecules | Eicosanoids in Nonalcoholic Fatty Liver Disease (NAFLD) Progression. Do Serum Eicosanoids Profile Correspond with Liver Eicosanoids Content during NAFLD Development and Progression? | 2020 | Details |
| A07814 | 32348835 | Life Sci | Exenatide ameliorates experimental non-alcoholic fatty liver in rats via suppression of toll-like receptor 4/NFκB signaling: Comparison to metformin. | 2020 | Details |
| A07815 | 32348210 | Curr Pharm Des | Hepatocellular Carcinoma in Non Alcoholic Fatty Liver Disease. | 2020 | Details |
| A07816 | 32347583 | FASEB J | Aberrant glycosaminoglycan biosynthesis by tumor suppressor EXTL2 deficiency promotes liver inflammation and tumorigenesis through Toll-like 4 receptor signaling. | 2020 | Details |
| A07817 | 32346447 | Exp Ther Med | Analysis of piRNA expression spectra in a non-alcoholic fatty liver disease mouse model induced by a methionine- and choline-deficient diet. | 2020 | Details |
| A07818 | 32346285 | Drug Des Devel Ther | Radix Polygoni Multiflori and Its Main Component Emodin Attenuate Non-Alcoholic Fatty Liver Disease in Zebrafish by Regulation of AMPK Signaling Pathway. | 2020 | Details |
| A07819 | 32345507 | Rev Gastroenterol Mex (Engl Ed) | Influence of socioeconomic and cultural factors in the etiology of cirrhosis of the liver. | 2020 | Details |
| A07820 | 32345506 | Rev Gastroenterol Mex (Engl Ed) | Hepatocellular carcinoma in the noncirrhotic liver: Clinical features and outcomes in Veracruz, Mexico. | 2020 | Details |
| A07821 | 32345225 | BMC Cardiovasc Disord | Higher fatty liver index is associated with increased risk of new onset heart failure in healthy adults: a nationwide population-based study in Korea. | 2020 | Details |
| A07822 | 32344934 | J Clin Med | Lipidomics Reveals Reduced Inflammatory Lipid Species and Storage Lipids after Switching from EFV/FTC/TDF to RPV/FTC/TDF: A Randomized Open-Label Trial. | 2020 | Details |
| A07823 | 32344559 | Metabolites | Distinguishing NASH Histological Severity Using a Multiplatform Metabolomics Approach. | 2020 | Details |
| A07824 | 32344052 | J Hepatol | Liver-related mortality is similar among men and women with cirrhosis. | 2020 | Details |
| A07825 | 32343421 | Hepatology | Thyroid Hormone Signaling and the Liver. | 2020 | Details |
| A07826 | 32343398 | Br J Pharmacol | Cyanidin-3-O-glucoside improves non-alcoholic fatty liver disease by promoting PINK1-mediated mitophagy in mice. | 2020 | Details |
| A07827 | 32343209 | Radiology | Advanced MRI of Liver Fibrosis and Treatment Response in a Rat Model of Nonalcoholic Steatohepatitis. | 2020 | Details |
| A07828 | 32343156 | Expert Rev Respir Med | Prevalence of, and risk factors for underweight or excess weight in patients with chronic obstructive emphysema from a multiethnic region of Xinjiang, China. | 2020 | Details |
| A07829 | 32342668 | Liver Int | Attenuated effect of PNPLA3 on hepatic fibrosis by HSD17B13 in Japanese patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A07831 | 32341228 | Saudi J Gastroenterol | Prevalence of biopsy-proven nonalcoholic fatty liver among patients with gallstone disease. | 2020 | Details |
| A07832 | 32341017 | J Pharmacol Exp Ther | 7α,25-Dihydroxycholesterol Suppresses Hepatocellular Steatosis through GPR183/EBI2 in Mouse and Human Hepatocytes. | 2020 | Details |
| A07833 | 32340286 | Int J Mol Sci | Nutrition and Genetics in NAFLD: The Perfect Binomium. | 2020 | Details |
| A07834 | 32340264 | Int J Mol Sci | Integrative Strategy of Testing Systems for Identification of Endocrine Disruptors Inducing Metabolic Disorders-An Introduction to the OBERON Project. | 2020 | Details |
| A07835 | 32339855 | Eur J Med Chem | Emerging targets and potential therapeutic agents in non-alcoholic fatty liver disease treatment. | 2020 | Details |
| A07836 | 32339374 | Liver Int | Disruption of Plin5 degradation by CMA causes lipid homeostasis imbalance in NAFLD. | 2020 | Details |
| A07839 | 32338202 | Curr Med Chem | Regulation of Apolipoprotein B by Natural Products and Nutraceuticals: A Comprehensive Review. | 2021 | Details |
| A07840 | 32337855 | Mol Syst Biol | The acute effect of metabolic cofactor supplementation: a potential therapeutic strategy against non-alcoholic fatty liver disease. | 2020 | Details |
| A07841 | 32337818 | Hepatol Res | Diagnostic accuracy of FibroScan-AST score to identify non-alcoholic steatohepatitis with significant activity and fibrosis in Japanese patients with non-alcoholic fatty liver disease: Comparison between M and XL probes. | 2020 | Details |
| A07842 | 32337667 | Dig Dis Sci | How Good Are Controlled Attenuation Parameter Scores from Fibroscan to Assess Steatosis, NASH, and Fibrosis? | 2020 | Details |
| A07843 | 32337295 | J Diabetes Res | Elevated Serum Level of Cytokeratin 18 M65ED Is an Independent Indicator of Cardiometabolic Disorders. | 2020 | Details |
| A07844 | 32337059 | BMJ Open Gastroenterol | Effectiveness of phosphatidylcholine as adjunctive therapy in improving liver function tests in patients with non-alcoholic fatty liver disease and metabolic comorbidities: real-life observational study from Russia. | 2020 | Details |
| A07845 | 32337056 | BMJ Open Gastroenterol | Changes in metabolic complications in patients with alcoholic fatty liver disease monitored over two decades: NAGALA study. | 2020 | Details |
| A07846 | 32336663 | Surg Obes Relat Dis | Is bariatric surgery resolving NAFLD via microbiota-mediated bile acid ratio reversal? A comprehensive review. | 2020 | Details |
| A07847 | 32336033 | J Dig Dis | Non-obese patients with nonalcoholic fatty liver disease may use a lower liver stiffness cut-off to assess fibrosis stages. | 2020 | Details |
| A07848 | 32335964 | J Gastroenterol Hepatol | Dietary patterns are associated with likelihood of hepatic steatosis among US adults. | 2020 | Details |
| A07849 | 32335952 | Rapid Commun Mass Spectrom | FGF-21 biomarker detection at the sub-nanogram per mL level in human serum using normal-flow liquid chromatography/tandem mass spectrometry. | 2020 | Details |
| A07850 | 32335723 | Appl Microbiol Biotechnol | Lactobacillus plantarum NA136 ameliorates nonalcoholic fatty liver disease by modulating gut microbiota, improving intestinal barrier integrity, and attenuating inflammation. | 2020 | Details |
| A07853 | 32333910 | Gastroenterology | Role of Cannabis and Its Derivatives in Gastrointestinal and Hepatic Disease. | 2020 | Details |
| A07855 | 32333454 | J Card Surg | Association between high dose catecholamine support and liver dysfunction following cardiac surgery. | 2020 | Details |
| A07856 | 32333452 | J Gastroenterol Hepatol | Metabolic profiles and fibrosis of nonalcoholic fatty liver disease in the elderly: A community-based study. | 2020 | Details |
| A07857 | 32333362 | Indian J Gastroenterol | The effect of PNPLA3 polymorphism as gain in function mutation in the pathogenesis of non-alcoholic fatty liver disease. | 2020 | Details |
| A07858 | 32332706 | Cell Death Dis | Neddylation of sterol regulatory element-binding protein 1c is a potential therapeutic target for nonalcoholic fatty liver treatment. | 2020 | Details |
| A07859 | 32331389 | Cells | The P2X7 Receptor and NLRP3 Axis in Non-Alcoholic Fatty Liver Disease: A Brief Review. | 2020 | Details |
| A07860 | 32331364 | Cells | The Emerging Role of MicroRNAs in NAFLD: Highlight of MicroRNA-29a in Modulating Oxidative Stress, Inflammation, and Beyond. | 2020 | Details |
| A07861 | 32331258 | Nutrients | Lemon Balm and Its Constituent, Rosmarinic Acid, Alleviate Liver Damage in an Animal Model of Nonalcoholic Steatohepatitis. | 2020 | Details |
| A07862 | 32330605 | J Hepatol | TGF-β1-driven reduction of cytoglobin leads to oxidative DNA damage in stellate cells during non-alcoholic steatohepatitis. | 2020 | Details |
| A07863 | 32330604 | J Hepatol | Animal models for liver disease - A practical approach for translational research. | 2020 | Details |
| A07864 | 32330603 | J Hepatol | Epitranscriptomics in liver disease: Basic concepts and therapeutic potential. | 2020 | Details |
| A07865 | 32330379 | Cell Physiol Biochem | Genistein and 17β-Estradiol Protect Hepatocytes from Fatty Degeneration by Mechanisms Involving Mitochondria, Inflammasome and Kinases Activation. | 2020 | Details |
| A07866 | 32329963 | J Diabetes Investig | Comparison of the effects of three kinds of glucose-lowering drugs on non-alcoholic fatty liver disease in patients with type 2 diabetes: A randomized, open-label, three-arm, active control study. | 2020 | Details |
| A07867 | 32329657 | Gut Microbes | Microbial and metabolic impacts of trehalose and trehalose analogues. | 2020 | Details |
| A07868 | 32329579 | Liver Int | Occult hepatitis B virus infection predicts non-alcoholic steatohepatitis in severely obese individuals from Italy. | 2020 | Details |
| A07869 | 32329453 | JNMA J Nepal Med Assoc | Burden of Alcoholic Liver Disease in a Tertiary Care Center: A Descriptive Cross-sectional Study. | 2020 | Details |
| A07870 | 32329085 | Hepatology | The L-α-Lysophosphatidylinositol/G Protein-Coupled Receptor 55 System Induces the Development of Nonalcoholic Steatosis and Steatohepatitis. | 2020 | Details |
| A07871 | 32328797 | J Gastroenterol | Nonalcoholic fatty liver disease: impact on healthcare resource utilization, liver transplantation and mortality in a large, integrated healthcare system. | 2020 | Details |
| A07872 | 32328031 | Front Endocrinol (Lausanne) | Higher Serum Uric Acid Level Predicts Non-alcoholic Fatty Liver Disease: A 4-Year Prospective Cohort Study. | 2020 | Details |
| A07873 | 32327942 | ScientificWorldJournal | Nonalcoholic Fatty Liver Disease and Coronary Artery Disease: Big Brothers in Patients with Acute Coronary Syndrome. | 2020 | Details |
| A07874 | 32326594 | Int J Environ Res Public Health | Fetuin-A and Fetuin-B in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis and Meta-Regression. | 2020 | Details |
| A07875 | 32326590 | Int J Mol Sci | Protein Deimination Signatures in Plasma and Plasma-EVs and Protein Deimination in the Brain Vasculature in a Rat Model of Pre-Motor Parkinson's Disease. | 2020 | Details |
| A07876 | 32326098 | Int J Mol Sci | LncRNAs Act as a Link between Chronic Liver Disease and Hepatocellular Carcinoma. | 2020 | Details |